Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02371421 · ClinicalTrials.gov registry record
Genetics of Hyperuricemia Therapy in Hmong
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 80
- Enrollment target
NCT02371421 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 80 participants.
The verdict
NCT02371421 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
To pursue this objective, we will be measuring uric acid at baseline and post 14 days of twice daily allopurinol therapy in 30 Hmong participants with documented gout or hyperuricemia and known genotype for key renal transporters of uric acid.
Interventions
- DRUG Allopurinol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2014-06 |
| Est. Completion | 2016-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02371421
The ClinicalTrials.gov registry entry for NCT02371421 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Allopurinol is the first listed.
NCT02371421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02371421 about?
NCT02371421 is a clinical study titled "Genetics of Hyperuricemia Therapy in Hmong". To pursue this objective, we will be measuring uric acid at baseline and post 14 days of twice daily allopurinol therapy in 30 Hmong participants with documented gout or hyperuricemia and known genotype for key renal transporters of uric acid.
What is the current status of trial NCT02371421?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2014-06. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02371421?
The interventions under investigation include: Allopurinol (DRUG).
Who is sponsoring clinical trial NCT02371421?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.